MedTrace Logo

Randomized and Multicenter Study to Evaluate a Customizable Support Breast Cancer Material

NCT05798312 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2023-04-04

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate if a customizable support material allows to improve the knowledge about the stage and subtype of the disease, as well as the indicated treatments, in comparison with a non-customizable support material among patients with breast cancer.

The main question it aims to answer is:

• What is the impact of delivering a customizable support material so that patients with breast cancer know and remember the stage and subtype of their disease, as well as the indicated treatments, compared to non-customizable support material?

Participants in the intervention group will be provided customizable support material while those in the standard group will receive a non-customizable material.

Conditions

  • Breast Cancer
  • Knowledge, Attitudes, Practice
  • Patient Empowerment
  • Patient Satisfaction

Interventions

OTHER

Customizable support material

Customizable support material will enable patients to identify their personal breast cancer information.

OTHER

Non-customizable support material

Non-customizable support material will include general breast cancer information.

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Medicos e Investigadores en la Lucha contra el Cancer de Mama

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-21
Primary Completion
2022-03-13
Completion
2022-03-13

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05798312 on ClinicalTrials.gov